CSIMarket



Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Net Cash Flow Growth by Quarter and Year

Pfizer Inc's Net Cash Flow results by quarter and year




PFE Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - -50.00 198.00 125.00
III Quarter October - -384.00 -218.00 -
II Quarter July - 608.00 -351.00 612.00
I Quarter April 529.00 -15.00 846.00 -
FY   529.00 159.00 475.00 737.00



PFE Net Cash Flow first quarter 2022 Y/Y Growth Comment
Pfizer Inc in the first quarter 2022 achieved Net Cash Flow of $ 529.00 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the first quarter 2022, Pfizer Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Pfizer Inc' s Net Cash Flow no change of % ranks overall at the positon no. 0 in the first quarter 2022.




PFE Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - - 58.4 % -
III Quarter October - - - -
II Quarter July - - - -
I Quarter April - - - -
FY   - -66.53 % -35.55 % -

Financial Statements
Pfizer Inc's first quarter 2022 Net Cash Flow $ 529.00 millions PFE's Income Statement
Pfizer Inc's first quarter 2021 Net Cash Flow $ -15.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Net Cash Flow Growth >>


PFE Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - - - -
III Quarter October - - - -
II Quarter July - - - -
I Quarter April - - 576.8 % -
FY (Year on Year)   - -66.53 % -35.55 % -




Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Net Cash Flow Y/Y Growth Statistics
High Average Low
895.45 % 149.44 % -97.77 %
(Sep. 30, 2011)   (Dec 31 2013)
Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Y/Y Growth Statistics
High Average Low
895.45 % 149.44 % -97.77 %
(Sep. 30, 2011)   (Dec 31 2013)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pfizer Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
1631.15 % 250.64 % -100 %
(Sep. 30, 2009)  


PFE's I. Quarter Q/Q Net Cash Flow Comment
Improvement I. Quarter 2022where Pfizer Inc published Net Cash Flow of $ 529.00 millions should be starting point of better results.Pfizer Inc announced in the I. Quarter 2022 Net Cash Flow of $ 529.00 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Pfizer Inc achieved highest sequential Net Cash Flow growth. While Pfizer Inc's Net Cash Flow growth quarter on quarter, overall rank is 0.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
1631.15 % 250.64 % -100 %
(Sep. 30, 2009)  


PFE's I. Quarter Q/Q Net Cash Flow Comment
This turnaround I. Quarter 2022where Pfizer Inc posted Net Cash Flow of $ 529.00 millions could be inception of positive performance.Pfizer Inc announced in the I. Quarter 2022 Net Cash Flow of $ 529.00 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Pfizer Inc achieved highest sequential Net Cash Flow growth. While Pfizer Inc's Net Cash Flow growth quarter on quarter, overall rank is 0.


Pfizer Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative Net Cash Flow 12 Months Ending $ 703.00 $ 159.00 $ 407.00 $ 573.00 $ -386.00
Y / Y Net Cash Flow Growth (TTM) - -66.53 % 1.24 % 7062.5 % -
Year on Year Net Cash Flow Growth Overall Ranking # # 1486 # 865 # 46 #
Seqeuential Net Cash Flow Change (TTM) 342.14 % -60.93 % -28.97 % - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 85 # 484 # 958 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Apr 03 2022 period, Pfizer Inc had cumulative twelve months Net Cash Flow of $ 703 millions compare to net cash outflow of $ -386 millions a year ago.
There is progress on the way, but very slow one, reporting below average 342.14 % Net Cash Flow advance, from $159 millions from the twelve months ending in the quarter Dec 31 2021 Marti Alonso said.

Pfizer Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While Total ranking has impoved so far to , from total ranking in previous quarter at 1486.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
4925 %
391.76 %
-99.18 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
7062.5 %
850.99 %
-81.13 %
(Jul 04 2021)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 19
S&P 500 # 85
Cumulative Net Cash Flow growth Comment
In the Apr 03 2022 period, Pfizer Inc had cumulative twelve months Net Cash Flow of $ 703 millions compare to net cash outflow of $ -386 millions a year ago.
There is revival on the way, although with caution, showing below average 342.14 % Net Cash Flow rise, from $159 millions from the twelve months ending in the quarter before.

Pfizer Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While Total ranking has impoved so far to , from total ranking in previous quarter at 1486.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
4925 %
391.76 %
-99.18 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
7062.5 %
850.99 %
-81.13 %
(Jul 04 2021)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 19
S&P 500 # 85




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PFE's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PFE's Competitors
Net Cash Flow Growth for Pfizer Inc's Suppliers
Net Cash Flow Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Apr 03 2022
Exelixis Inc -25.99%$ -25.985 millions
National Vision Holdings Inc -88.65%$ -88.653 millions
Illumina Inc -95.46%$ -95.463 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NMGX's Profile

Stock Price

NMGX's Financials

Business Description

Fundamentals

Charts & Quotes

NMGX's News

Suppliers

NMGX's Competitors

Customers & Markets

Economic Indicators

NMGX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071